These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 24131828)
1. [Pulmonary vascular remodeling in congenital cardiovascular abnormalities: an eternal topic]. Liu HM Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):805-9. PubMed ID: 24131828 [TBL] [Abstract][Full Text] [Related]
2. [Pulmonary arterial hypertension in adult patients with congenital heart disease]. Serino G; Giacomazzi F Pediatr Med Chir; 2010; 32(6):274-9. PubMed ID: 21462449 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiological and metabolic manifestations of pulmonary vascular disease in children. Haworth SG Herz; 1992 Aug; 17(4):254-61. PubMed ID: 1398433 [TBL] [Abstract][Full Text] [Related]
4. [Female gender and pulmonary arterial hypertension: a complex relationship]. Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877 [TBL] [Abstract][Full Text] [Related]
6. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463 [TBL] [Abstract][Full Text] [Related]
7. Lessons from oncology to understand and treat pulmonary hypertension. Adnot S; Eddahibi S Int J Clin Pract Suppl; 2007 Dec; (158):19-25. PubMed ID: 18078390 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647 [TBL] [Abstract][Full Text] [Related]
13. [Pulmonary hypertension and pulmonary vascular disease in congenital heart defects]. Keck EW Z Kardiol; 1989; 78 Suppl 7():65-73. PubMed ID: 2696259 [TBL] [Abstract][Full Text] [Related]
14. [Pediatric pulmonary hypertension and pulmonary arterial hypertension secondary to congenital heart diseases]. Olguntürk R Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():50-6. PubMed ID: 20819767 [TBL] [Abstract][Full Text] [Related]
15. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension. Jiang L; Zhou T; Liu H Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545 [TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension. Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740 [TBL] [Abstract][Full Text] [Related]
17. Pathology and pathobiology of pulmonary hypertension. Guignabert C; Dorfmuller P Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. Luan Y; Zhang X; Kong F; Cheng GH; Qi TG; Zhang ZH Int Immunopharmacol; 2012 Dec; 14(4):432-7. PubMed ID: 22922316 [TBL] [Abstract][Full Text] [Related]
19. [Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases]. Zhang CJ; Huang YG; Shen JJ; Huang T; Huang WH; Cui YL; Huang XS Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):65-8. PubMed ID: 21418801 [TBL] [Abstract][Full Text] [Related]